Current Pharmaceutical Biotechnology


Nikolaos Labrou
Department of Biotechnology
Agricultural University of Athens

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Editorial [ Are Peptide Therapeutics the Future? Guest Editor: Sivaram Pillarisetti ] promotion: free to download

Volume:7   Issue: 4
Pp: 225-227
Sivaram Pillarisetti
DOI: 10.2174/138920106777950799

Novel Therapies Based on Cationic Antimicrobial Peptides

Volume:7   Issue: 4
Pp: 229-234
H. Anne Pereira
DOI: 10.2174/138920106777950771

Atherosclerosis and Vascular Disease: Effects of Peptide Mimetics of Apolipoproteins

Volume:7   Issue: 4
Pp: 235-240
David W. Garber, Shaila P. Handattu, Geeta Datta, Vinod K. Mishra, Himanshu Gupta, C. Roger White and G. M. Anantharamaiah
DOI: 10.2174/138920106777950834

Emerging Peptide Therapeutics for Inflammatory Diseases

Volume:7   Issue: 4
Pp: 241-246
Maya Vally, Sujatha Seenu and Sivaram Pillarisetti
DOI: 10.2174/138920106777950816

Novel Delivery Technologies for Protein and Peptide Therapeutics

Volume:7   Issue: 4
Pp: 261-276
T. R. Shantha Kumar, K. Soppimath and S. K. Nachaegari
DOI: 10.2174/138920106777950852

Accounting for Triplet and Saturation Effects in FCS Measurements

Volume:7   Issue: 4
Pp: 287-301
Lloyd M. Davis and Guoqing Shen
DOI: 10.2174/138920106777950843